Tarrytown, NY, United States of America

Manuel Allen Revez Ferreira

USPTO Granted Patents = 12 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Manuel Allen Revez Ferreira

Introduction

Manuel Allen Revez Ferreira is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of medical science, particularly in the treatment of various immune disorders and conditions such as sepsis. With a total of 12 patents to his name, Ferreira's work has the potential to impact many lives.

Latest Patents

Ferreira's latest patents include groundbreaking methods for treating sepsis using PCSK9 and LDLR modulators. This patent outlines methods for treating subjects with sepsis, SIRS, septic shock, and/or MODS. It also includes techniques for identifying individuals at increased risk of developing these conditions and methods for detecting Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) variant nucleic acid molecules and polypeptides. Another significant patent focuses on treating MHC-I-opathy risk haplotypes. This patent provides methods for treating subjects with immune disorders by administering a therapeutically effective amount of an Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) inhibitor in combination with an HLA-A29 or HLA-B27 inhibitory nucleic acid molecule.

Career Highlights

Ferreira is currently associated with Regeneron Pharmaceuticals, Inc., where he continues to innovate and develop new therapeutic methods. His work at Regeneron has positioned him as a key player in the pharmaceutical industry, contributing to advancements in treatment options for complex medical conditions.

Collaborations

Some of Ferreira's notable coworkers include Aris I Baras and Luca Andrea Lotta. Their collaborative efforts have likely contributed to the success of the projects they have undertaken together.

Conclusion

Manuel Allen Revez Ferreira's contributions to medical science through his patents and work at Regeneron Pharmaceuticals, Inc. highlight his dedication to improving healthcare outcomes. His innovative approaches to treating serious medical conditions demonstrate the importance of research and development in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…